• Latest Posts
In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

FDA approves Beyfortus ahead of 2023-24 RSV season

SandboxAQ launches new division to boost drug development

Sanofi drug reduces disease activity in relapsing MS

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

Expert Advice 2 Mar 2023

5 steps to strategic partnerships for healthtech startups


Sanofi hemophilia drug gets FDA approval

Dupixent gets EU nod for children with severe atopic dermatitis

CytoReason expands deal with Sanofi to look at IBD

Positive Dupixent eosinophilic esophagitis phase 3 results

Sanofi and Innate Pharma expand natural killer cell deal

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine